Literature DB >> 22361020

Functional magnetic resonance imaging correlates of memory encoding in relation to achieving remission in first-episode schizophrenia.

Michael Bodnar1, Amelie M Achim, Ashok K Malla, Ridha Joober, Audrey Benoit, Martin Lepage.   

Abstract

BACKGROUND: Previous studies in schizophrenia have shown a strong relationship between memory deficits and a poor clinical outcome. However, no previous study has identified the functional neural correlates of memory encoding in relation to remission. AIMS: To determine whether functional magnetic resonance imaging (fMRI) activation patterns differed between individuals that later achieved remission v. those who did not.
METHOD: Forty-two participants with first-episode schizophrenia were divided into two groups after 1 year of treatment as per the 2005 remission in schizophrenia consensus definition. We then examined fMRI activation using three contrasts (associative v. item-oriented strategy, semantically unrelated v. related image pairs, and successful v. unsuccessful memory encoding) among 15 participants who had achieved remission (remitted group), 27 who had not (non-remitted group) and 31 healthy controls (control group).
RESULTS: Participants in the non-remitted group displayed a positive activation in the posterior cingulate compared with those in the remitted group when encoding related images; no significant differences between the two groups were identified for the other contrasts. From the behavioural data, compared with the remitted and control groups, the non-remitted group demonstrated an inability to encode related images and displayed worse recognition memory overall.
CONCLUSIONS: This is the first study to identify differential neural activation between individuals with first-episode schizophrenia that later achieved remission v. those who did not. The behavioural and functional results together add to the growing evidence relating a poor clinical outcome in schizophrenia to memory-related deficits.

Entities:  

Mesh:

Year:  2012        PMID: 22361020     DOI: 10.1192/bjp.bp.111.098046

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  6 in total

Review 1.  Neuroimaging markers of antipsychotic treatment response in schizophrenia: An overview of magnetic resonance imaging studies.

Authors:  Goda Tarcijonas; Deepak K Sarpal
Journal:  Neurobiol Dis       Date:  2018-06-25       Impact factor: 5.996

2.  Using longitudinal imaging to map the 'relapse signature' of schizophrenia and other psychoses.

Authors:  V L Cropley; C Pantelis
Journal:  Epidemiol Psychiatr Sci       Date:  2014-05-22       Impact factor: 6.892

3.  FDG-PET scans in patients with Kraepelinian and non-Kraepelinian schizophrenia.

Authors:  Marie-Cécile Bralet; Monte S Buchsbaum; Alex DeCastro; Lina Shihabuddin; Serge A Mitelman
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-09-14       Impact factor: 5.270

Review 4.  Neuroimaging schizophrenia: a picture is worth a thousand words, but is it saying anything important?

Authors:  Anthony O Ahmed; Peter F Buckley; Mona Hanna
Journal:  Curr Psychiatry Rep       Date:  2013-03       Impact factor: 5.285

Review 5.  Machine learning approaches: from theory to application in schizophrenia.

Authors:  Elisa Veronese; Umberto Castellani; Denis Peruzzo; Marcella Bellani; Paolo Brambilla
Journal:  Comput Math Methods Med       Date:  2013-12-09       Impact factor: 2.238

6.  White matter integrity as a predictor of response to treatment in first episode psychosis.

Authors:  Tiago Reis Marques; Heather Taylor; Chris Chaddock; Flavio Dell'acqua; Rowena Handley; A A T Simone Reinders; Valeria Mondelli; Stefania Bonaccorso; Marta Diforti; Andrew Simmons; Anthony S David; Robin M Murray; Carmine M Pariante; Shitij Kapur; Paola Dazzan
Journal:  Brain       Date:  2013-11-19       Impact factor: 15.255

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.